Borderzone Infarcts and Recurrent Cerebrovascular Events in Symptomatic Intracranial Arterial Stenosis: A Systematic Review and Meta-Analysis.

Borderzone Infarct Intracranial arterial diseases Intracranial atherosclerosis Recurrence Stroke

Journal

Journal of stroke
ISSN: 2287-6391
Titre abrégé: J Stroke
Pays: Korea (South)
ID NLM: 101602023

Informations de publication

Date de publication:
May 2023
Historique:
received: 19 01 2023
accepted: 04 05 2023
medline: 7 6 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

Intracranial arterial stenosis (ICAS)-related stroke occurs due to three primary mechanisms with distinct infarct patterns: (1) borderzone infarcts (BZI) due to impaired distal perfusion, (2) territorial infarcts due to distal plaque/thrombus embolization, and (3) plaque progression occluding perforators. The objective of the systematic review is to determine whether BZI secondary to ICAS is associated with a higher risk of recurrent stroke or neurological deterioration. As part of this registered systematic review (CRD42021265230), a comprehensive search was performed to identify relevant papers and conference abstracts (with ≥20 patients) reporting initial infarct patterns and recurrence rates in patients with symptomatic ICAS. Subgroup analyses were performed for studies including any BZI versus isolated BZI and those excluding posterior circulation stroke. The study outcome included neurological deterioration or recurrent stroke during follow-up. For all outcome events, corresponding risk ratios (RRs) and 95% confidence intervals (95% CI) were calculated. A literature search yielded 4,478 records with 32 selected during the title/abstract triage for full text; 11 met inclusion criteria and 8 studies were included in the analysis (n=1,219 patients; 341 with BZI). The meta-analysis demonstrated that the RR of outcome in the BZI group compared to the no BZI group was 2.10 (95% CI 1.52-2.90). Limiting the analysis to studies including any BZI, the RR was 2.10 (95% CI 1.38-3.18). For isolated BZI, RR was 2.59 (95% CI 1.24-5.41). RR was 2.96 (95% CI 1.71-5.12) for studies only including anterior circulation stroke patients. This systematic review and meta-analysis suggests that the presence of BZI secondary to ICAS may be an imaging biomarker that predicts neurological deterioration and/or stroke recurrence.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Intracranial arterial stenosis (ICAS)-related stroke occurs due to three primary mechanisms with distinct infarct patterns: (1) borderzone infarcts (BZI) due to impaired distal perfusion, (2) territorial infarcts due to distal plaque/thrombus embolization, and (3) plaque progression occluding perforators. The objective of the systematic review is to determine whether BZI secondary to ICAS is associated with a higher risk of recurrent stroke or neurological deterioration.
METHODS METHODS
As part of this registered systematic review (CRD42021265230), a comprehensive search was performed to identify relevant papers and conference abstracts (with ≥20 patients) reporting initial infarct patterns and recurrence rates in patients with symptomatic ICAS. Subgroup analyses were performed for studies including any BZI versus isolated BZI and those excluding posterior circulation stroke. The study outcome included neurological deterioration or recurrent stroke during follow-up. For all outcome events, corresponding risk ratios (RRs) and 95% confidence intervals (95% CI) were calculated.
RESULTS RESULTS
A literature search yielded 4,478 records with 32 selected during the title/abstract triage for full text; 11 met inclusion criteria and 8 studies were included in the analysis (n=1,219 patients; 341 with BZI). The meta-analysis demonstrated that the RR of outcome in the BZI group compared to the no BZI group was 2.10 (95% CI 1.52-2.90). Limiting the analysis to studies including any BZI, the RR was 2.10 (95% CI 1.38-3.18). For isolated BZI, RR was 2.59 (95% CI 1.24-5.41). RR was 2.96 (95% CI 1.71-5.12) for studies only including anterior circulation stroke patients.
CONCLUSION CONCLUSIONS
This systematic review and meta-analysis suggests that the presence of BZI secondary to ICAS may be an imaging biomarker that predicts neurological deterioration and/or stroke recurrence.

Identifiants

pubmed: 37282372
pii: jos.2023.00185
doi: 10.5853/jos.2023.00185
pmc: PMC10250880
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

223-232

Références

J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2580-7
pubmed: 26283519
Stroke. 2018 Jun;49(6):e221-e223
pubmed: 29720438
Neurol Res. 2015 May;37(5):385-90
pubmed: 25917464
J Neuroimaging. 2014 Jan-Feb;24(1):11-7
pubmed: 22818110
Eur Neurol. 2010;64(2):95-100
pubmed: 20616559
Int J Stroke. 2006 Aug;1(3):158-9
pubmed: 18706036
Stroke. 2005 Mar;36(3):567-77
pubmed: 15692123
JAMA. 2022 Aug 9;328(6):534-542
pubmed: 35943472
Circ Res. 2017 Feb 3;120(3):502-513
pubmed: 28154100
J Stroke Cerebrovasc Dis. 2016 Feb;25(2):469-74
pubmed: 26654665
JAMA Neurol. 2016 Feb;73(2):178-85
pubmed: 26720181
Arch Neurol. 1998 Nov;55(11):1475-82
pubmed: 9823834
Stroke. 2009 Jun;40(6):2276-93
pubmed: 19423857
Lancet Neurol. 2013 Nov;12(11):1106-14
pubmed: 24135208
Stroke. 2021 Jun;52(6):1961-1966
pubmed: 33866818
Neuroradiology. 2020 Sep;62(9):1123-1131
pubmed: 32300828
J Neurointerv Surg. 2018 Dec;10(12):1161-1163
pubmed: 29602861
Lancet. 2014 Jan 25;383(9914):333-41
pubmed: 24168957
JAMA Neurol. 2016 May 1;73(5):572-8
pubmed: 26998948
J Neuroimaging. 2019 Sep;29(5):640-644
pubmed: 31112323
Stroke. 2018 Jan;49(1):e10-e13
pubmed: 29167389
N Engl J Med. 2011 Sep 15;365(11):993-1003
pubmed: 21899409
Cerebrovasc Dis. 2013;35(3):268-75
pubmed: 23548833
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Stroke. 2018 Dec 11;:STROKEAHA118020840
pubmed: 30580705
Cochrane Database Syst Rev. 2019 Oct 3;10:ED000142
pubmed: 31643080
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
JAMA. 2015 Mar 24-31;313(12):1240-8
pubmed: 25803346
J Neuroimaging. 2020 Jul;30(4):468-470
pubmed: 32579278
Stroke. 2017 Aug;48(8):2158-2163
pubmed: 28679857
Stroke. 2009 Dec;40(12):3730-5
pubmed: 19797182
J Neuroimaging. 2021 Jul;31(4):686-690
pubmed: 33930227
Neurology. 1995 Apr;45(4):659-63
pubmed: 7723951
Stroke. 2019 May;50(5):1286-1293
pubmed: 31009344
Stroke. 2020 Mar;51(3):e49-e53
pubmed: 32078441

Auteurs

Saurav Das (S)

Department of Neurology, University of Kentucky, Louisville, KY, USA.

Liqi Shu (L)

Department of Neurology, Brown University, Providence, RI, USA.

Rebecca J Morgan (RJ)

University of Kentucky Medical Center Library, Louisville, KY, USA.

Asghar Shah (A)

Department of Neurology, Brown University, Providence, RI, USA.

Fayez H Fayad (FH)

Department of Neurology, Brown University, Providence, RI, USA.

Eric D Goldstein (ED)

Department of Neurology, Brown University, Providence, RI, USA.

Dalia Chahien (D)

Royal College of Surgeons, Dublin, Ireland.

Benton Maglinger (B)

Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Satish Kumar Bokka (SK)

Department of Neurology, West Virginia University, Morgantown, WV, USA.

Cory Owens (C)

Department of Neurology, University of Kentucky, Louisville, KY, USA.

Mehdi Abbasi (M)

Department of Neurology, Yale University, New Haven, CT, USA.

Alexandra Kvernland (A)

Department of Neurology, NYU Langone health, New York, NY, USA.

James E Siegler (JE)

Department of Neurology, Cooper University Hospital, Camden, NJ, USA.

Brian Mac Grory (BM)

Department of Neurology, Duke University, Durham, NC, USA.

Thanh N Nguyen (TN)

Department of Neurology, Boston University Medical Center, Boston, MA, USA.

Karen Furie (K)

Department of Neurology, Brown University, Providence, RI, USA.

Pooja Khatri (P)

Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, USA.

Eva Mistry (E)

Department of Neurology and Rehabilitation Medicine, University of Cincinnati, Cincinnati, OH, USA.

Shyam Prabhakaran (S)

Department of Neurology, University of Chicago, Chicago, IL, USA.

David S Liebeskind (DS)

Department of Neurology, University of California at Los Angeles, Los Angeles, CA, USA.

Jose G Romano (JG)

Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.

Adam de Havenon (A)

Department of Neurology, Yale University, New Haven, CT, USA.

Lina Palaiodimou (L)

Second Department of Neurology, National and Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece.

Georgios Tsivgoulis (G)

Second Department of Neurology, National and Kapodistrian University of Athens, "Attikon" University Hospital, Athens, Greece.

Shadi Yaghi (S)

Department of Neurology, Brown University, Providence, RI, USA.

Classifications MeSH